Histology of portal vascular changes associated with idiopathic non-cirrhotic portal hypertension: nomenclature and definition Idiopathic non-cirrhotic portal hypertension (INCPH) is a rare vascular liver disease that has attracted new interest in recent years. It is characterised by clinical signs of portal hypertension in the absence of cirrhosis or severe fibrosis and any known cause of portal hypertension. As much uncertainty exists about INCPH pathophysiology, and no definite diagnostic tests are available, liver biopsy is an essential tool for achieving a definite diagnosis. Unfortunately, the histological diagnosis of INCPH is not always straightforward, as the characteristic lesions are unevenly distributed, vary greatly in their severity, are often very subtle, and are not all necessarily present in a single case. Furthermore, specifically for the characteristic portal vessel changes observed in
Introduction
Idiopathic non-cirrhotic portal hypertension (INCPH) is a vascular liver disease of unknown aetiology, characterised by clinical signs of portal hypertension (PH) in the absence of cirrhosis. 1 Therefore, INCPH is frequently revealed by splenomegaly, thrombocytopenia, oesophageal varices and/or variceal bleeding in patients with preserved liver function. The diagnosis of INCPH requires exclusion of any disorders known to cause PH in the absence of cirrhosis (e.g. infiltrative diseases, vascular malignancies, schistosomiasis, congenital hepatic fibrosis, and sarcoidosis) and other known causes of liver disease. 1, 2 A variety of terms were introduced for this noncirrhotic liver disease, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] such as Banti syndrome, non-cirrhotic portal fibrosis, hepatoportal sclerosis, incomplete septal cirrhosis, obliterative portal venopathy, and nodular regenerative hyperplasia. After the recognition that these names appear to reflect a disease entity, albeit with heterogeneous morphological aspects, 7 the umbrella term INCPH was introduced to standardise the nomenclature. 1 Idiopathic non-cirrhotic portal hypertension is relatively rare, particularly in western countries, but it is probably underdiagnosed or misdiagnosed, because, on clinical presentation, it closely mimics 'cryptogenic cirrhosis'. 8 The lack of pathognomonic clinical and laboratory findings makes the histological examination of liver tissue samples critically important to achieve a definite diagnosis of INCPH.
1,2 INCPH liver may show a variety of lesions. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] The most characteristic encompass a constellation of portal/periportal vascular changes, supposedly involved in the pathogenesis. However, the histopathological diagnosis of INCPH is not always straightforward, as the characteristic lesions are unevenly distributed, vary greatly in their severity, are often very subtle, and are not all necessarily present in an individual case. 11, 13 The limited sampling obtained by liver biopsy presents further challenges in recognising relevant histological features. Therefore, the pathologist who is not aware of the clinical background, and/or does not include INCPH in the differential diagnosis, may miss the subtle morphological changes of this condition. The scenario is even more complicated in that it is now recognised that, in cases of INCPH, vascular lesions may be seen at earlier stages, when clinical signs of PH are still lacking, or even never develop or are never documented. 12, 14, 15 Furthermore, the specificity and sensitivity of these histopathological changes are currently unknown, as they can be also seen outside the context of PH in chronic conditions of different aetiologies. 16, 17 To add to the complexity, standard nomenclature and definitions of characteristic INCPH portal lesions are lacking, which greatly contributes to the problems in diagnosing this entity.
The semantic confusion clearly reflects (but also contributes to) our uncertainties surrounding the pathogenesis and clinical meaning of the observed portal vascular lesions. Clear morphological definitions and terminology will enable follow-up studies, which can determine the utility of these definitions, and their potential impact on understanding the pathophysiology, and/or their value in guiding clinical management of the patients.
The present article was written after a 3-day meeting of the International Liver Pathology Study Group, also known as the 'Elves', 18 devoted to vascular liver lesions, which was held in Padova (Italy) in 2015. We worked to arrive at a consensus on the definition and nomenclature for the portal/periportal microvascular changes characteristic of INCPH that can assist clinical and investigative pathologists in recognising the histopathological features and applying them in a consistent fashion, which is necessary for gaining a better understanding of this disease.
For the sake of thematic focus, this article is not a comprehensive review of the histopathology of INCPH. Therefore, pathological entities, such as nodular regenerative hyperplasia or incomplete septal cirrhosis, which are known to be associated with INCPH, or common accompanying lesions (sinusoidal dilatation and terminal hepatic vein enlargement) are not considered. For a comprehensive approach to the diagnosis of INCPH, readers are referred to the available literature. 11, 13, 19 The goal of this article is to recommend a system of standardised nomenclature, so as to overcome the inconsistency of the current terminology used for the characteristic INCPH portal/periportal vascular changes.
The definitions and recommendations are based on what we have observed in routine liver biopsies, using routine stains (H&E and collagen stain). We use adjunctive stains for specific purposes, for example reticulin stain is useful when nodular regenerative hyperplasia is suspected in INCPH.
It is worth emphasising not only that the portal/ periportal lesions may be variably combined in a single biopsy specimen, but also that different lesions may coexist in a same portal/periportal area, and in some cases, it might be difficult to differentiate one from the other. As small vascular structures are affected in INCPH, one should try to derive and construct their three-dimensional behaviour from the routine consecutive liver biopsy sections that are obtained for a liver biopsy. Besides providing a better sense of the three-dimensional architecture of a lesion, following such lesions through all levels will help in identifying the different lesions properly. As was demonstrated by Crawford et al. in their study of normal liver biopsies, 20 one-section-only may be not as informative as following findings-of-interest through the many levels of a routine liver biopsy.
Normal histology of intrahepatic portal vasculature
In normal adult liver biopsy, most portal tracts (PTs) contain portal vein (PV), hepatic artery and bile duct profiles. Portal 'dyads' containing only hepatic artery and bile duct profiles, representing terminal PTs, are also commonly seen and should not be considered to be pathological. 20, 21 The successive branches of the smaller PVs are the preterminal portal venules, found in PTs of triangular cross-sections, and the terminal portal venules (approximately 20-30 lm in diameter) surrounded by scanty connective tissue in PTs of circular cross-sections. 21 In normal peripheral PTs, hepatic arteries and bile ducts show similar diameters, whereas PV profiles are, on average, three times greater in minimum diameter and can be up to four times greater. 20 PVs are entirely confined to the PT, and connect to sinusoids through the inlet venules. These are very short side branches that have an endothelial lining with a basement membrane and scanty adventitial fibrous connective tissue but no smooth muscle in their walls. 20 Inlet venules are usually not visible in normal conditions.
Portal and periportal changes in INCPH
In INCPH, the portal venous radicles show variable degrees of luminal narrowing, disappearance, or sclerosis. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] 19, 22 This change usually occurs in a fibrotic PT. Indeed, round fibrous PT enlargement is characteristic of INCPH. 23 The percentage of PTs involved and the degree of fibrosis are variable. As the diameter of a normal PV branch is at least three times greater than that of the bile duct, comparing their calibres in the same PT may help to identify a narrowed PV (its calibre may be similar to, or even smaller than, that of the bile duct). For larger PVs, luminal narrowing may be recognised by identifying the smooth muscle fibres of the PV as revealing the original contour of this structure, and determining whether the endothelial lining delineates a smaller luminal space. The endothelial lining may be highlighted by CD34 staining, although obliteration of the PV lumen will also eliminate immunoreactive endothelial cells. The presence of a circumferential profile of smooth muscle fibres without any interior lumen is a sign of luminal disappearance. Identification of a narrowed PV in the smallest PTs may be very difficult. However, the presence of fibrosis along with an eccentrically placed hepatic artery/bile duct pair is a helpful sign of PV disappearance. This histological sign is different from identifying a true hepatic artery/bile duct 'dyad', as the latter lacks fibrosis and has a delicate investment of extracellular matrix that wraps around only the hepatic artery and bile duct profiles, without any additional cross-sectional area. The overall impression of PV loss can also be supported by performing a 'profile count' of one entire liver biopsy histological section. With a minimum of seven PT profiles that are not at the edge of the biopsy sample, a 'paucity' of PVs may be appreciated. (The normal percutaneous liver biopsy has PVs in 70% of PTs, inclusive of both PTs with PVs/hepatic arteries/ bile ducts, and 'dyads' with hepatic artery/bile duct pairs only. 20 
)
In the literature, different terms have been used to refer to this alteration, which is regarded as the initial lesion of INCPH leading to increased intrahepatic resistance. Mikkelsen et al. 6 introduced the term 'phlebosclerosis'. Obliterative portal venopathy, 2,5,12,24 PV obliteration, 7 hepatoportal sclerosis 9,25 and small PV obliteration 26 are other terms that are commonly used.
The term phlebosclerosis is misleading, as sclerosis of the PV wall is not invariably present. Indeed, in the article by Verheij et al., 27 phlebosclerosis was defined as 'a portal vein with a reduced lumen in a fibrotic portal tract'. The other terms have been differently defined, and are often used to refer either to the clinical syndrome or to the entire spectrum of vascular changes seen in INCPH. For example, Nayak and Ramalingaswami 5 defined obliterative portal venopathy as 'scarring and obliteration of small portal vein branches along with an increased number of small vascular channels within the portal tracts and incomplete thin fibrous septa'. As emphasised above, the entire spectrum of portal vascular changes is not necessarily found in every case of INCPH, particularly in liver biopsy samples. Furthermore, the PV is not always obliterated; its lumen may be narrowed but still visible. Therefore, a term that refers only to the PV branch lesion, which may be an isolated change, and a more clear definition are advisable. We suggest naming this lesion simply PV stenosis. The word stenosis comes from ancient Greek, and in medicine means pathological narrowing of a lumen, which may be more or less severe and even complete.
Recommended term: PV stenosis. Definition: incomplete or complete obliteration of PV branches AE thickening of the wall (Figure 1 ; Table 1 ).
P O R T A L / P E R I P O R T A L V E N O U S A L T E R A T I O N S
Portal vascular spaces directly abutting the hepatic parenchyma at the limiting plate is a frequent finding in INCPH, 9, 11, 13, 25, 28, 29 giving the appearance of a prolapsed PV. This is thought to be rarely or never seen in normal livers. Indeed, in normal liver, a PV is entirely confined to the PT and is separated from the hepatocytes by connective tissue. 21 Matsumoto, who first observed this change in liver with Banti's syndrome, 28 coined the term 'aberrant vessel'. Ohbu et al. 29 provided a detailed histopathological classification of portal vascular changes in cases of non-cirrhotic PH, and called this alteration 'type II aberrant vessel', defining it as 'an aberrant vessel connected to the peripheral portal vein'. However, with the term 'aberrant vessels', they covered both intraportal and periportal vascular abnormalities, which do not necessarily coexist. Others applied the term aberrant vessels to periportal vessels only. 30, 31 Yet others called this lesion 'herniated PV' 25 or simply considered it to be a component of 'hepatoportal sclerosis' without using specific terminology. Another commonly used term is 'shunt vessels'. 9, 19, 32, 33 However, some authors used 'shunt vessels' to refer to periportal abnormal vasculature. 33 Furthermore, it is not clear whether these abnormal vessels were really shunts. In the study by Ohbu et al., 29 using serial paraffin sections, these vessels were seen opening into sinusoids, indicating that they were not intrahepatic shunts connected to the terminal hepatic veins, but that they presumably represented dilated inlet venules. Indeed, these vascular structures have thin walls, similarly to the inlet venules. While we await a better understanding of the pathogenic events that lead to this change, we suggest keeping the most descriptive term among those available, i.e. 'herniated PV'. This term immediately reflects the impression that we have when looking at the biopsy. We strongly recommend abandoning all of the other terminologies.
Recommended term: herniated PV. Definition: a PV from the PT directly abutting periportal parenchyma (Figure 2 ; Table 1 ). 
I N C R E A S E I N T H E N U M B E R O F P O R T A L V A S C U L A R S P A C E S
An increased number of thin-walled vascular spaces in PTs, often without an effective PV, is a well-recognised morphological feature of INCPH, and was first described by Mikkelsen et al. in 1965 . 6 This finding has also been included in the description of hepatoportal sclerosis. 10 Nayak et al. 7 considered them as obliterative change of smaller branches, and defined them as 'few small capillary-like venous channels dispersed in the fibrosed portal tracts'. However, the size of these vessels was variable. Krasinksas et al. 16 referred to such alteration as 'fragmentation' of PV radicles, and included it under the umbrella of aberrant vessels. Other terms used in the literature included 'PT angiomatosis', 'angiomatoid lesion', 23 and 'angiomatous transformation of the PT'. 34 It is very unlikely that such an anomaly reflects neoplastic or malformed vascular proliferation, as the terminology might suggest; its pathogenesis remains unknown. We suggest discontinuing the use of these different names and replacing them with the descriptive, non-committal term 'hypervascularised PT', which simply means that there are more vascular structures than expected in a normal PT.
Recommended term: hypervascularised PT. Definition: multiple thin-walled vascular spaces in the PT (Figure 3 ; Table 1 ).
P E R I P O R T A L V E S S E L S
Periportal changes in INCPH consist of abnormal vascular spaces immediately adjacent to a PT, which may or may not contain a normal PV. 11, 13, 19, 25, 29 Periportal abnormal vascular spaces may be single or multiple, with lumens of different sizes. Similar changes have been found in cases of extrahepatic PV obstruction and nodular regenerative hyperplasia, both of which are known to be associated with noncirrhotic PH. The origin of these vascular spaces is also not clear. Fukuda et al. 35 provided evidence that they were portal in nature, on autopsy and biopsy materials of idiopathic PH, and in experimental animal models. The various terms used to refer to this abnormality include aberrant vessels, 16, 28, 29 cavernous transformation, 25 paraportal shunting vessels, 7 and megasinusoids. 36, 37 As already observed, 'aberrant vessels' has been used as an umbrella term that also includes intraportal vessel changes. Both angiomatoid malformation and cavernous transformation are ambiguous terms. In the common medical language, malformation means deviation from normal morphology, usually on a genetic/congenital basis. Cavernous transformation of the PV currently indicates a rare condition consisting of portosystemic or portoportal collaterals that develop as long-term sequelae of PV thrombosis. We also discourage the use of the terms 'paraportal shunting vessels' and 'megasinusoids', as neither the shunt function nor the sinusoidal origin are proven. In addition, the term megasinusoid has been used to describe sinusoidal ectasia, which is a common accompanying change in cases of INCPH.
To avoid confusion about the unclear origin of this vascular abnormality, we again recommend using a purely descriptive term, and suggest naming this finding 'periportal abnormal vessels'.
Recommended term: periportal abnormal vessels. Definition: single or multiple thin-walled vascular spaces of different calibre outside, but in close contact, with the PT (Figure 4 ; Table 1 ). 
Conclusion
Aiming at simplification and providing a basis for standardisation, the nomenclature proposed herein is intended to be descriptive enough to be used without pathophysiological implications. Our knowledge of the causes and morphogenesis of vascular alterations and of the natural history of INCPH is still unsatisfactory. The use of consistent nomenclature and definitions in both clinical and research settings will facilitate future investigations and standardisation of diagnostic criteria.
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